Business
Analysts Predict Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) To Reach 115 In 12 Months
In recent trading session, Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) saw 0.61 million shares changing hands at last check today with its beta currently measuring 0.26. Company’s
